| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $8,177,239 ) (Continued on the next page) |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK139288 | Mitochondrial DAMPs-driven Mechanisms of Liver Fibrosis in NASH | 000 | 3 | NIH | 1/27/2026 | $682,579 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA257672 | Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy | 000 | 4 | NIH | 1/22/2026 | $640,361 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258776 | Pan-Cancer characterization of 3’UTR somatic mutations controlling tumor immune evasion | 000 | 5 | NIH | 1/16/2026 | $507,623 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG079864 | Brain Vulnerability in Delirium and Alzheimer’s Disease and Related Dementias: Intersection of Polygenic Risk and Inflammation | 000 | 4 | NIH | 12/12/2025 | $741,776 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG051658 | AD/ADRD and biological aging proteomic signatures in the etiopathology of delirium and its associated long-term cognitive decline | 000 | 8 | NIH | 1/20/2026 | $761,853 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R00AG065495 | Supplement Multifunctional Tough Adhesive Hydrogels to Recruit, Expand, and Deliver Tendon Cells During Aging and Injury | 000 | 5 | NIH | 1/21/2026 | $121,030 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23HL177335 | Plasma protein markers of the blood pressure response during exercise and their relation to incident hypertension and cardiovascular disease | 000 | 2 | NIH | 2/12/2026 | $190,338 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K99NS140561 | Identification of a Circuit Basis for Neuropathic Pain in the Parabrachial Nucleus | 000 | 2 | NIH | 12/12/2025 | $124,713 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS122589 | Neuronal Circuit Controlling Sleep-Promoting Ventrolateral Preoptic Neurons | 000 | 5 | NIH | 1/19/2026 | $337,669 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01MH116170 | Cerebellar Modulation of Cognition in Psychosis | 000 | 8 | NIH | 12/3/2025 | $827,269 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK130929 | Corticosteroids to Reduce Inflammation in Severe Pancreatitis (CRISP) | 000 | 5 | NIH | 12/17/2025 | $380,380 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK135672 | Cav1.2 in bladder physiology and pathology | 000 | 3 | NIH | 2/11/2026 | $540,966 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK138503 | Integrating signals that control APOL1 gene expression and drive kidney disease | 000 | 13 | NIH | 1/12/2026 | $540,299 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK137983 | CYP4F Enzymes Regulate N-Acyl Amino Acid Signaling in Humans | 000 | 2 | NIH | 12/15/2025 | $731,254 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA285395 | Resolution of inflammation in chemical-induced cancer | 000 | 2 | NIH | 12/17/2025 | $643,748 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA276107 | Control of cancer cachexia via stimulation of resolution of inflammation | 000 | 3 | NIH | 1/13/2026 | $622,526 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG086786 | Orexins and severity of menopausal symptoms in mice | 000 | 1 | NIH | 11/26/2025 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AR062173 | The IL-23/IL-17 Axis in Inflammatory Arthritis | 000 | 10 | NIH | 12/4/2025 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG068141 | The Trajectories and Clinical Experiences of ICD Therapy (TRACER-ICD) Study | 000 | 5 | NIH | 12/31/2025 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG070077 | Neurobiological mechanisms of altered cortical plasticity in Type-2 diabetes mellitus | 000 | 5 | NIH | 12/4/2025 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R00CA259329 | Elucidating a Novel Mechanism for LATS1/2 in Suppressing Tumorigenesis | 000 | 5 | NIH | 11/18/2025 | -$73,437 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K24AG071906 | Research and mentoring program in shared decision making in the care of older adults | 000 | 5 | NIH | 1/20/2026 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23AT011043 | Understanding components of mind-body exercise for physical activity engagement in metabolic syndrome | 000 | 5 | NIH | 1/5/2026 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23AG068364 | Understanding the structural, functional, and prognostic implications of cortical excitability in Alzheimer's disease | 000 | 5 | NIH | 2/3/2026 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 001 | 5 | NIH | 2/2/2026 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 001 | 5 | NIH | 2/2/2026 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 001 | 5 | NIH | 2/2/2026 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 001 | 5 | NIH | 2/2/2026 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 001 | 5 | NIH | 2/2/2026 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 5 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 5 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 5 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 5 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 5 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | U24HL166784 | 2/2: PREcision VENTilation to attenuate Ventilation-Induced Lung Injury (PREVENT VILI) | 000 | 3 | NIH | 12/11/2025 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | U01AI145801 | Ad26 Based Therapeutic Vaccines for HIV | 000 | 6 | NIH | 2/2/2026 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | T32HL155020 | Training Program in Resuscitation Science | 000 | 5 | NIH | 1/21/2026 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21AI176120 | Development and Characterization of Phage QBeta-Based SARS-CoV-2 RT-qPCR Assay Calibration Standards | 000 | 2 | NIH | 10/7/2025 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS119223 | Neural Mechanisms Underlying Cataplexy Control by MCH Neurons | 000 | 5 | NIH | 2/5/2026 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL161385 | Using Machine Learning to find a life saving needle in a haystack of children's emergencies | 000 | 4 | NIH | 11/5/2025 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL171042 | Regulation of coagulation and thrombosis by C1 inhibitor | 000 | 2 | NIH | 12/2/2025 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NR019628 | Biochemical profiling to identify cardiometabolic responsiveness to an endurance exercise intervention | 000 | 5 | NIH | 12/1/2025 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL155717 | Myocardial Radiomics and Mechanics in the Pathology and Prognosis of Cardiovascular Disease | 000 | 5 | NIH | 1/13/2026 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL157991 | Mapping & quantifying lymphatic drainage of the arm's alternate pathway | 000 | 5 | NIH | 11/21/2025 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK132284 | Structure-Guided Design of Intestine-Selective AHR Agonists for Restoration of Gut Barrier Integrity in IBD | 000 | 4 | NIH | 1/14/2026 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK133948 | CalR: A toolkit and repository for experiments of energy homeostasis using indirect calorimetry | 000 | 4 | NIH | 10/24/2025 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01EB032824 | Immunoevasive Engineered Living Blood Vessels | 000 | 4 | NIH | 2/2/2026 | $0 |
| | 2026 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK140473 | Decreased SRD5A2 and Alternative Estrogen Signaling in Prostatic Cell Survival | 000 | 2 | NIH | 1/23/2026 | $0 |
| | 2026 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG072899 | Inflammasome activation in modulation of Alzheimer's Disease by alcohol | 000 | 5 | NIH | 1/22/2026 | -$2,875 |
|
